SE0202461D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE0202461D0
SE0202461D0 SE0202461A SE0202461A SE0202461D0 SE 0202461 D0 SE0202461 D0 SE 0202461D0 SE 0202461 A SE0202461 A SE 0202461A SE 0202461 A SE0202461 A SE 0202461A SE 0202461 D0 SE0202461 D0 SE 0202461D0
Authority
SE
Sweden
Prior art keywords
novel compounds
compounds
racemates
tautomers
inhibitors
Prior art date
Application number
SE0202461A
Other languages
English (en)
Inventor
Jan Dahmen
Martin Hemmerling
Tomas Klingstedt
Peter Sjoe
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0202461A priority Critical patent/SE0202461D0/sv
Publication of SE0202461D0 publication Critical patent/SE0202461D0/sv
Priority to AU2003258922A priority patent/AU2003258922A1/en
Priority to PCT/SE2003/001278 priority patent/WO2004016615A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
SE0202461A 2002-08-14 2002-08-14 Novel compounds SE0202461D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0202461A SE0202461D0 (sv) 2002-08-14 2002-08-14 Novel compounds
AU2003258922A AU2003258922A1 (en) 2002-08-14 2003-08-13 PYRAZOLO (4,3c) CINNOLINE COMPOUNDS AS INHIBITORS OF ITK KINASE ACTIVITY
PCT/SE2003/001278 WO2004016615A1 (en) 2002-08-14 2003-08-13 PYRAZOLO (4,3c) CINNOLINE COMPOUNDS AS INHIBITORS OF ITK KINASE ACTIVITY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0202461A SE0202461D0 (sv) 2002-08-14 2002-08-14 Novel compounds

Publications (1)

Publication Number Publication Date
SE0202461D0 true SE0202461D0 (sv) 2002-08-14

Family

ID=20288749

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0202461A SE0202461D0 (sv) 2002-08-14 2002-08-14 Novel compounds

Country Status (3)

Country Link
AU (1) AU2003258922A1 (sv)
SE (1) SE0202461D0 (sv)
WO (1) WO2004016615A1 (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008122405A (ru) * 2005-12-20 2010-01-27 Астразенека Аб (Se) Замещенные производные циннолина в качестве модуляторов гамма-рецепторов и способ их синтеза
US7465795B2 (en) 2005-12-20 2008-12-16 Astrazeneca Ab Compounds and uses thereof
WO2007126913A1 (en) * 2006-03-27 2007-11-08 The Government Of The U.S.A. As Represented By The Secretary Department Of Health & Human Services Methods for prevention or treatment of viral disease
WO2013153539A1 (en) 2012-04-13 2013-10-17 Glenmark Pharmaceuticals S.A. Tricyclic compounds as tec kinase inhibitors
KR20230170797A (ko) 2013-10-25 2023-12-19 파마싸이클릭스 엘엘씨 이식편 대 숙주 질환의 치료 및 예방 방법
CA2996177A1 (en) 2015-08-31 2017-03-09 Pharmacyclics Llc Btk inhibitor combinations for treating multiple myeloma
CA3042049A1 (en) 2016-11-03 2018-05-11 Juno Therapeutics, Inc. Combination therapy of a t cell therapy and a btk inhibitor
UA125800C2 (uk) 2017-06-30 2022-06-08 Баєр Енімал Хелс Гмбх Похідні азахіноліну
MX2020011527A (es) 2018-05-03 2021-02-26 Juno Therapeutics Inc Terapia de combinación de una terapia de células t-receptor de antígeno quimérico (car) y un inhibidor de cinasa.
WO2023220655A1 (en) 2022-05-11 2023-11-16 Celgene Corporation Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549833B1 (fr) * 1983-07-26 1985-11-08 Roussel Uclaf Derives de la pyrazolo /4,3-c/ cinnolin-3-one, leurs sels, procede de preparation, application a titre de medicaments, compositions les renfermant et produits intermediaires
JPS61112075A (ja) * 1984-11-05 1986-05-30 Shionogi & Co Ltd チエニルピラゾロキノリン誘導体
US4591589A (en) * 1985-01-16 1986-05-27 Roussel Uclaf 2-aryl pyrazolo[4,3-c]cinnolin-3-ones

Also Published As

Publication number Publication date
AU2003258922A1 (en) 2004-03-03
WO2004016615A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
SE0202463D0 (sv) Novel compounds
UA84878C2 (ru) Производные 2-пиридона как ингибиторы нейтрофилов эластазы, фармацевтическая композиция на их основе, способ их получения
SE0302486D0 (sv) Novel compounds
MY137133A (en) Novel compounds
HK1089163A1 (en) Quinoxaline derivatives as neutrophil elastase inhibitors and their use
SE0302323D0 (sv) Novel compounds
MX2007009372A (es) Nuevos compuestos ii derivados de 2-piridina como inhibidores de elastasa neutrofila.
UY29246A1 (es) Nuevos compuestos
NO20044995L (no) Heterosykliske forbindelser
NI201000085A (es) Derivados bis - (sulfonilamino) en terapia 066.
NO20063231L (no) Pyrido[2,3-D]pyrimidin-2,4-diaminer som PDE 2 inhibitorer
ATE394383T1 (de) Biphenylkarbonsäureamidderivate als p38 kinase- inhibitoren
GB0112348D0 (en) Compounds
ATE477256T1 (de) Thienylverbindungen
SE0203304D0 (sv) Novel Coumpounds
TW200628153A (en) Novel compounds
SE0302756D0 (sv) Novel Compounds
SE0202461D0 (sv) Novel compounds
GB0308201D0 (en) Novel compounds
ATE246174T1 (de) Tosylprolin-derivate als thymidylat-synthase inhibitoren
SE9904676D0 (sv) Novel compounds
SE9901901D0 (sv) Compounds
SE0000477D0 (sv) Novel compounds
SE9904677D0 (sv) Novel compounds
SE0302120D0 (sv) Novel compounds